Frequency News and Research

RSS

Eisai reports new data analyses on FYCOMPA (Perampanel) at AES meeting

Today, Eisai Inc. announced that 16 abstracts highlighting new data analyses on FYCOMPA (perampanel) will be presented at the 67th annual American Epilepsy Society (AES) meeting, taking place in Washington, D.C. from December 6 – 10.

6 Dec 2013

INTENSIA family of ICDs and CRT-D devices receive CE mark approval

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that the INTENSIA family of implantable cardioverter defibrillators and cardiac resynchronization therapy devices received CE (Conformité Européenne) mark approval. This family of devices includes the single-chamber INTENSIA VR, the dual-chamber INTENSIA DR and the INTENSIA SonR® CRT-D devices, all of which feature a DF-4 high voltage connector.

6 Dec 2013

Baylor researchers study outcomes and effectiveness of traumatic brain injury rehabilitation

For patients recovering from a traumatic brain injury (TBI), the rehabilitation process - compensating for changes in functioning, adaptation and even community reintegration - can be challenging.

6 Dec 2013

Study examines correlation between polyunsaturated fatty acids in blood and risk of PTSD

A study published in the current issue of Psychotherapy and Psychosomatics has examined the correlation between polyunsaturated fatty acids in the blood and the risk of post-traumatic stress disorder.

6 Dec 2013

Cardiac patients benefit from home-based high intensity training

Rapid rehabilitation is a must after a heart attack or other cardiovascular event. Different forms of exercise as a part of rehabilitation have been examined by researchers, including high-intensity interval training (85-95 % of maximum heart rate), which has proved to be both a good and efficient form of rehabilitation.

5 Dec 2013

Genocea commences GEN-004 Phase 1 study to prevent pneumococcus infections

Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for pneumococcus (Streptococcus pneumoniae), a major cause of infectious disease-related death globally. GEN-004 is the first vaccine candidate designed to prevent infections caused by all strains of pneumococcus through a novel T cell-mediated mechanism of action.

5 Dec 2013

Older people ingest too much magnesium, vitamin E in the form of dietary supplements

Many older people are ingesting too much magnesium and vitamin E in the form of dietary supplements. This was discovered by scientists of the Helmholtz Zentrum München in a population-based study; their results have been published in 'The Journal of Nutrition, Health and Aging'.

5 Dec 2013

Long-term ECG may help patients suffering from chronic cardiac insufficiency

Patients suffering from cardiac diseases may rapidly become emergencies. Then, seconds decide about life and death. However, many cardiac diseases are announced several months before. Symptoms are simply overlooked. A long-term ECG may help. A sensor belt developed at KIT for the first time allows to document cardiac activity of a patient over a long term all around the clock for up to six months. The sensor belt is now presented by the researchers at the Medica trade fair in Düsseldorf.

5 Dec 2013

New method for counting tumor-fighting cells to predict ovarian cancer

One way to predict survival of many types of cancer is by counting the number of tumor-attacking immune cells that have migrated into the tumor in an effort to eradicate it - a sign of the body's immune response to the cancer. However, quantifying these armies of immune cells has been difficult - until now.

5 Dec 2013

Update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation procedures

Uroplasty, Inc. a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today provided an update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation (PTNS) procedures delivered via the Company's Urgent® PC Neuromodulation System for treatment of overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency and urge incontinence.

4 Dec 2013

Takeda and Teva announce agreement related to commercialization of glatiramer acetate in Japan

Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited (Takeda) today announced the signing earlier this year of an agreement in which Teva licensed to Takeda the right to commercialize Teva's innovative glatiramer acetate ( active ingredient) formulation for the treatment of multiple sclerosis, in Japan.

4 Dec 2013

LabCorp's HCV GenoSure NS3/4 test now available for Q80K polymorphism screening

Laboratory Corporation of America Holdings announced today the immediate availability of an enhanced version of its HCV GenoSure NS3/4, a drug resistance test that screens for the Q80K polymorphism. Q80K is a naturally occurring polymorphism that develops in certain strains of HCV, making the virus less susceptible to Janssen Therapeutics' OLYSIO (simeprevir), which was recently approved by the U.S. Food and Drug Administration for the treatment of certain adult patients diagnosed with genotype 1chronic hepatitis C.

3 Dec 2013

Europe needs to plan for future probabilities of extreme weather, reports EASAC

Europe needs to plan for future probabilities of extreme weather. Heat waves, floods and storms do not respect national frontiers, so there is a need for action at both national and EU levels.

3 Dec 2013

Study explores social and emotional impact of Tourette syndrome in secondary schools

Secondary school can be a stressful enough time for any teenager, but for those living with Tourette Syndrome (TS) their neurological condition can present a whole new set of challenges.

3 Dec 2013

Evidence reveals bronchial thermoplasty has long-term benefit for asthma patients

The beneficial effects of bronchial thermoplasty, a non-pharmacologic treatment for asthma, last at least five years, according to researchers at National Jewish Health and other institutions.

3 Dec 2013

CPCs not powerful enough to be used as a single tool in diagnosis of acute myocardial infarction

Using chest pain characteristics (CPCs) specific to women in the early diagnosis of acute myocardial infarction (AMI, heart attack) in the emergency department does not seem to be supported by the findings of a study published by JAMA Internal Medicine, a JAMA Network publication.

27 Nov 2013

OPOs’ efforts to enforce FPA is inconsistent and incomplete, shows study

All 50 states and the District of Columbia have adopted the 2006 Revised Uniform Anatomical Gift Act (UAGA) or enacted similar legislation giving individuals the "First Person Authorization" (FPA) to consent to organ donation after death via a signed donor card or driver's license, or by enrollment in a donor registry.

27 Nov 2013

International researchers report significant findings on vascular abnormality outside the brain

Studies on Alzheimer's disease and other forms of dementia have long focused on what's happening inside the brain. Now an international research team studying Alzheimer's and mild cognitive impairment is reporting potentially significant findings on a vascular abnormality outside the brain.

27 Nov 2013

Researchers find that hay fever and allergies make migraines worse

People with migraine who also battle allergies and hay fever (rhinitis) endure a more severe form of headaches than their peers who struggle with migraine, but aren't affected by the seasonal or year-round sniffles, according to researchers from the University of Cincinnati, Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University and Vedanta Research.

26 Nov 2013

Sacral neuromodulation stands test of time in LUTD

Follow-up of patients at a Belgian institution reveals that sacral neuromodulation is effective for the treatment of lower urinary tract dysfunction over the long term, but often requires reintervention.

From Medtronic 25 Nov 2013

Frequency News and Research

Eisai reports new data analyses on FYCOMPA (Perampanel) at AES meeting

INTENSIA family of ICDs and CRT-D devices receive CE mark approval

Baylor researchers study outcomes and effectiveness of traumatic brain injury rehabilitation

Study examines correlation between polyunsaturated fatty acids in blood and risk of PTSD

Cardiac patients benefit from home-based high intensity training

Genocea commences GEN-004 Phase 1 study to prevent pneumococcus infections

Older people ingest too much magnesium, vitamin E in the form of dietary supplements

Long-term ECG may help patients suffering from chronic cardiac insufficiency

New method for counting tumor-fighting cells to predict ovarian cancer

Update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation procedures

Takeda and Teva announce agreement related to commercialization of glatiramer acetate in Japan

LabCorp's HCV GenoSure NS3/4 test now available for Q80K polymorphism screening

Europe needs to plan for future probabilities of extreme weather, reports EASAC

Study explores social and emotional impact of Tourette syndrome in secondary schools

Evidence reveals bronchial thermoplasty has long-term benefit for asthma patients

CPCs not powerful enough to be used as a single tool in diagnosis of acute myocardial infarction

OPOs’ efforts to enforce FPA is inconsistent and incomplete, shows study

International researchers report significant findings on vascular abnormality outside the brain

Researchers find that hay fever and allergies make migraines worse

Sacral neuromodulation stands test of time in LUTD

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News